Marc Van Ranst
Marc Van Ranst (born in Bornem on 20 June 1965) is a Belgian virologist at the Katholieke Universiteit Leuven (Leuven, Belgium) and the Rega Institute for Medical Research. On 1 May 2007 he was appointed as Interministerial comissionar by the Belgian federal government to prepare Belgium for an influenza pandemic.
Marc Van Ranst | |
---|---|
Born | |
Nationality | Belgian |
Alma mater | KU Leuven Albert Einstein College of Medicine |
Scientific career | |
Fields | Virology |
Institutions | KU Leuven |
Education
Van Ranst obtained a BA in medicine at Hasselt University (then L.U.C.) in 1986 and later graduated as a medical doctor at the Katholieke Universiteit Leuven in 1990. From 1990 to 1993, he worked at the Department of Microbiology and Immunology at Albert Einstein College of Medicine in New York, and received his PhD degree in virology in 1994.[1] He also specialized in Laboratory Medicine (1998) for which he obtained a PhD at the K.U. Leuven.
Career
Academic career
He started working at the University Hospitals Leuven in 1999 and became Professor of Virology at the K.U. Leuven.[1] Currently, he is associate chief of the department of laboratory medicine, and heads the diagnostic virology laboratory at the University Hospitals Leuven, Belgium. He is also the director of the AIDS reference laboratory and of the national coronavirus and rotavirus reference laboratories. Professor Van Ranst was appointed in 1999 to the Belgian high council for public health, where he heads the vaccination department.[1] Since 2012, he is the Chairman of the Department of Microbiology and Immunology at the KU Leuven. In his research laboratory, six PhD students and four MSc students are currently working on studies on the molecular evolution of DNA and RNA viruses.[1]
Teaching
Professor Van Ranst teaches virology and computational genomics at the Faculty of Medicine at the KU Leuven.[2] Since 1995, he holds an affiliate academic position at the Faculty of Natural Sciences at Charles University in Prague, where he teaches Bioinformatics.[1]
Science communication
He published over 270 scientific papers in peer reviewed journals[1] and contributed eight chapters to books on molecular evolution and bioinformatics.
Marc Van Ranst is the chairman of the editorial board of VacciNews.net,[3] a social media platform that provides accurate information on vaccines.
Lead in Belgian influenza crisis management
- Since 2007, responsible for influenza pandemic preparedness planning[1]
- 2009–2010: responsible as interministerial commissary for crisis management during the Mexican flu pandemic[1]
- 2020: for the COVID-19-pandemic, Marc Van Ranst is member both of the Belgian 'Risk Assessment Group' (RAG), which analyses the risks of coronavirus SARS-CoV-2 for public health, and of the 'Scientific committee Coronavirus' which advises Belgian health authorities on combatting the virus and which makes prognoses on its evolution and spread in Belgium.[5]
Social media
Van Ranst is very active on social media, particularly Twitter, where he addresses both professional and societal issues.[6] In August 2014, he was the first person who used the term Gazacaust that created heavy reactions in the Jewish community in Belgium and abroad.[7][8] Van Ranst is also a target of social media campaigns by right-wing Flemish nationalists in Belgium, for instance, in 2018 former interior minister Theo Francken nick-named Van Ranst as Doctor Hatred.[9]
References
- MARC VAN RANST https://eip-pediatrics-conference.ineip.org/marc_van_ranst
- CLINICAL VIROLOGY https://rega.kuleuven.be/cev/mvr
- VacciNewsNet
- Winners of the Heine-Medin Award https://www.escv.eu/awards/heine-medin-award/
- Coronavirus COVID-19, belgium.be
- @vanranstmarc https://twitter.com/vanranstmarc
- Van Ranst botst met Joods Actueel: "Laat mijn grootouders hierbuiten!"
- "Philosémitisme: L'obsession anti-Israël du médecin flamand Marc van Ranst". 7 August 2014.
- Twitteroorlog tussen Theo Francken en Marc Van Ranst escaleert: "Hij vervalst Facebook-posts" versus "Hij trekt mijn integriteit in twijfel" https://www.nieuwsblad.be/cnt/dmf20180912_03738291
- Van Ranst M., Chandipura virus: an emerging human pathogen?, Lancet. 2004 September 4–10;364(9437):821-2.